An Observational Study for Investigating the Frequency of FGFR2 Gene Fusion in Unresectable Advanced or Metastatic Cholangiocarcinomasaddddddc

An Observational Study for Investigating the Frequency of FGFR2 Gene Fusion in Unresectable Advanced or Metastatic Cholangiocarcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1080225086

Enrollment

550

Registered

2020-02-25

Start date

2020-01-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CholangiocarcinomaCholangiocarcinoma

Interventions

investigational material(s) Generic name etc : - INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : - control material(

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Provide written informed consent 2.Male or female subjects age >= 20 years at the time of informed consent 3.Subjects with a histologically or cytologically diagnosis of intrahepatic or perihilar cholangiocarcinoma 4.Subjects with surgically unresectable or advanced/metastatic disease 5.Subjects with Performance Status (PS) score of 0 1 established by Eastern Cooperative Oncology Group (ECOG) 6.Subjects who are expected to survive for 3 months or longer after Informed consent.

Exclusion criteria

Exclusion criteria: 1. History of active malignancy (except for primary tumor or definitively treated melanoma in-situ, basal or squamous cell carcinoma of the skin, carcinoma in-situ of the cervix, or early stage colorectal cancer) within the past 24 months prior to informed consent 2. Patients with prior therapy targeting FGFR2 3. Any subjects who are judged by the principal investigator or sub-investigators to be inappropriate as subjects in this study

Design outcomes

Primary

Measure	Time frame
exploratory Frequency of FGFR2 Gene Fusion	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026